Literature DB >> 23183780

[Principles of glucocorticoid therapy].

J Ehrchen1.   

Abstract

The principles of systemic glucocorticoid (GC) therapy in dermatology are reviewed. As a basis for an efficient GC therapy with few side effects the pharmacology, endogenous regulation as well as the mechanisms and side effects of GCs as well as their management are introduced. Modern therapeutic approaches such as circadian application and low-dose therapy are discussed as well as principles of tapering dosages and the most important indications for systemic GCs in dermatology.

Mesh:

Substances:

Year:  2012        PMID: 23183780     DOI: 10.1007/s00105-012-2471-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  9 in total

Review 1.  [High dosage steroid pulse therapy. Is there an indication in dermatology?].

Authors:  U Reinhold; F Buttgereit
Journal:  Hautarzt       Date:  2000-10       Impact factor: 0.751

Review 2.  Glucocorticoids.

Authors:  Cornelia M Spies; Cindy Strehl; Marlies C van der Goes; Johannes W J Bijlsma; Frank Buttgereit
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-12       Impact factor: 4.098

Review 3.  American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  Jennifer M Grossman; Rebecca Gordon; Veena K Ranganath; Chad Deal; Liron Caplan; Weiling Chen; Jeffrey R Curtis; Daniel E Furst; Maureen McMahon; Nivedita M Patkar; Elizabeth Volkmann; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07-26       Impact factor: 4.794

4.  Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes.

Authors:  Jan Ehrchen; Lars Steinmüller; Katarzyna Barczyk; Klaus Tenbrock; Wolfgang Nacken; Martin Eisenacher; Ursula Nordhues; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

Review 5.  Update on the dermatologic use of systemic glucocorticosteroids.

Authors:  Scott Jackson; Heidi Gilchrist; Lee T Nesbitt
Journal:  Dermatol Ther       Date:  2007 Jul-Aug       Impact factor: 2.851

6.  EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Authors:  J N Hoes; J W G Jacobs; M Boers; D Boumpas; F Buttgereit; N Caeyers; E H Choy; M Cutolo; J A P Da Silva; G Esselens; L Guillevin; I Hafstrom; J R Kirwan; J Rovensky; A Russell; K G Saag; B Svensson; R Westhovens; H Zeidler; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

7.  Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.

Authors:  Dedee F Murrell; Sarah Dick; A R Ahmed; Masayuki Amagai; Maria A Barnadas; Luca Borradori; Jean-Claude Bystryn; Giuseppe Cianchini; Luis Diaz; David Fivenson; Russell Hall; Karen E Harman; Takashi Hashimoto; Michael Hertl; Nico Hunzelmann; Pilar Iranzo; Pascal Joly; Marcel F Jonkman; Yasuo Kitajima; Neil J Korman; Linda K Martin; Daniel Mimouni; Amit G Pandya; Aimee S Payne; David Rubenstein; Hiroshi Shimizu; Animesh A Sinha; David Sirois; Detlef Zillikens; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2008-03-14       Impact factor: 11.527

Review 8.  Genomic and nongenomic effects of glucocorticoids.

Authors:  Cindy Stahn; Frank Buttgereit
Journal:  Nat Clin Pract Rheumatol       Date:  2008-09-02

Review 9.  Optimised glucocorticoid therapy: the sharpening of an old spear.

Authors:  Frank Buttgereit; Gerd-Rüdiger Burmester; Brian J Lipworth
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

  9 in total
  2 in total

1.  The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy).

Authors:  Josef Georg Heckmann; Peter Paul Urban; Susanne Pitz; Orlando Guntinas-Lichius; Ildikό Gágyor
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

Review 2.  More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages.

Authors:  Jan M Ehrchen; Johannes Roth; Katarzyna Barczyk-Kahlert
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.